E. Testa

Low-Dose Monitored Mitotane Treatment Achieves the Therapeutic Range with Manageable Side Effects in Patients with Adrenocortical Cancer¹

Massimo Terzolo, Anna Pia, Alfredo Berruti et al. · The Journal of Clinical Endocrinology & Metabolism · 2000 · 116 citations · Full text

Pharmacy, Oncology, Pharmacology +15

Potential role of levocarnitine supplementation for the treatment of chemotherapy-induced fatigue in non-anaemic cancer patients

Francesco Graziano, Renato Bisonni, Vincenzo Catalano et al. · British Journal of Cancer · 2002 · 107 citations · Full text

Medicine, Oncology, Pharmacology +13

Second-line chemotherapy for patients with advanced gastric cancer: who may benefit?

Vincenzo Catalano, Francesco Graziano, Daniele Santini et al. · British Journal of Cancer · 2008 · 104 citations · Full text

Medicine, Oncology, Chemotherapy +7

Intensive weekly chemotherapy for advanced gastric cancer using fluorouracil, cisplatin, epi-doxorubicin, 6S-leucovorin, glutathione, and filgrastim: a report from the Italian Group for the Study of Digestive Tract Cancer.

Stefano Cascinu, Roberto Labianca, Paolo Alessandroni et al. · Journal of Clinical Oncology · 1997 · 103 citations

Medicine, Oncology, Pharmacology +13

Pharmacogenetic profiling in patients with advanced colorectal cancer treated with first-line FOLFIRI chemotherapy

Annamaria Ruzzo, Francesco Graziano, Fotios Loupakis et al. · The Pharmacogenomics Journal · 2007 · 101 citations

Medicine, Oncology, Pharmacology +16